Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Bone morphogenetic proteins (e.g., BMP9\; MIM 605120) are members of the transforming growth factor-beta (see TGFB1\; MIM 190180) superfamily and regulate tissue differentiation and maintenance. Additionally we are shipping GDF15 Kits (71) and GDF15 Proteins (35) and many more products for this protein.
Showing 10 out of 281 products:
Chimpanzee Polyclonal GDF15 Primary Antibody for EIA, WB - ABIN453964
Baek, Eling: Changes in gene expression contribute to cancer prevention by COX inhibitors. in Progress in lipid research 2006
Show all 2 references for ABIN453964
Chimpanzee Polyclonal GDF15 Primary Antibody for EIA, WB - ABIN453966
Lindmark, Zheng, Wiklund, Bensen, Bälter, Chang, Hedelin, Clark, Stattin, Meyers, Adami, Isaacs, Grönberg, Xu: H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. in Journal of the National Cancer Institute 2004
Show all 2 references for ABIN453966
Human Polyclonal GDF15 Primary Antibody for ELISA, WB - ABIN185465
Wollmann, Goodman, Bhat-Nakshatri, Kishimoto, Goulet, Mehrotra, Morimiya, Badve, Nakshatri: The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. in Carcinogenesis 2005
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease.
We identified five new biomarkers: GDF15, osteonectin (show SPARC Antibodies), TRAP5, TWEAK (show TNFSF12 Antibodies), and YKL40 (show CHI3L1 Antibodies) as being promising markers for monitoring bone metastases.
In community-dwelling aged individuals, our findings suggest that high serum MIC-1/GDF15 levels indicate reduced white matter integrity and possibly greater white matter pathology.
repeated cisterna magna administration of human umbilical cord blood-derived mesenchymal stem cells enhanced endogenous adult hippocampal neurogenesis and synaptic activity through a paracrine factor of GDF-15
analysis of animal and clinical studies and patent updates of GDF-15 in diabetes and cardiovascular diseases [review]
GDF15 knockdown induced epithelial-mesenchymal transition.
GDF-15 and FGF-21 (show FGF21 Antibodies) are elevated in mitochondrial diseases
Cerebrospinal GDF15, but not MMP9 (show MMP9 Antibodies), may be a potential marker of Lewy body disorders.
Transgenic mice expressing human non-steroidal anti-inflammatory drug activated gene 1 (NAG-1) have less adipose tissue, improved insulin (show INS Antibodies) sensitivity, lower insulin (show INS Antibodies) levels and are resistant to dietary induced obesity.
Serum levels of GDF15 in primary myelofibrosis are elevated, and GDF15 may modulate the pathogenesis of primary myelofibrosis by enhancing proliferation and promoting osteogenic differentiation of bone marrow mesenchymal stromal cells.
endogenous Growth/differentiation factor-15 is beneficial for axon regeneration following sciatic nerve crush
Levels of GDF-15 mRNA increased 2 h after induction of ventilator-induced lung injury in WT lungs. Non-hematopoietic cells are the main source of GDF-15. GDF-15 is required for platelet-leukocyte interactions during ventilator-induced lung injury.
hNAG-1 appears to be a novel therapeutic target in preventing and treating obesity and insulin (show INS Antibodies) resistance.
Counterbalance between MIC-1 and ATF3 (show ATF3 Antibodies) is critical for deciding the fate of enterocytes under the food chemical stress.
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
Growth/differentiation factor 15 promotes EGFR (show EGFR Antibodies) signalling, and regulates proliferation and migration in the hippocampus of neonatal and young adult mice.
GDF-15 is therefore prominently upregulated in the retina after optic nerve crush but does not directly interfere with the magnitude and temporal progression of retinal ganglion cell death.
GDF15 protects the renal interstitium and tubular compartment in experimental type 1 and 2 diabetes without affecting glomerular damage
Enteropathogenic Escherichia coli enhances MIC-1 gene expression in the human intestinal cancer cells
Bone morphogenetic proteins (e.g., BMP9\; MIM 605120) are members of the transforming growth factor-beta (see TGFB1\; MIM 190180) superfamily and regulate tissue differentiation and maintenance. They are synthesized as precursor molecules that are processed at a dibasic cleavage site to release C-terminal domains containing a characteristic motif of 7 conserved cysteines in the mature protein.
growth differentiation factor 15
, NSAID (nonsteroidal anti-inflammatory drug)-activated protein 1
, NSAID-activated gene 1 protein
, NSAID-regulated gene 1 protein
, growth/differentiation factor 15
, macrophage inhibitory cytokine 1
, placental TGF-beta
, placental bone morphogenetic protein
, prostate differentiation factor
, macrophage inhibiting cytokine-1